CJC-1295 without drug affinity complex is the short-acting Mod GRF 1-29 peptide. Compare half-life, research dosing, and safety with the DAC version.
CJC-1295 without the drug affinity complex — frequently labeled Mod GRF 1-29 — is a synthetic peptide studied as a growth hormone-releasing hormone (GHRH) analog that lacks the DAC molecule used to extend half-life. Without DAC, the peptide is cleared from the body in roughly 30 minutes instead of several days, so research protocols typically involve more frequent administration. Neither version is FDA-approved for human use in the United States.
What “Without Drug Affinity Complex” Actually Means
The drug affinity complex (DAC) is a maleimidopropionic acid group that binds to serum albumin after injection. That binding acts like a reservoir, keeping the peptide in circulation far longer and producing a sustained rise in growth hormone rather than a short pulse.
Remove the DAC and the four amino acid substitutions remain, so the peptide still resists enzymatic breakdown better than native GRF 1-29. What disappears is the albumin binding, which is why the no-DAC version has such a short duration of action.
Among researchers, commonly cited cjc 1295 without dac benefits include a more pulsatile growth hormone pattern and faster clearance, which some argue more closely mimics the body’s natural rhythm of GH release.
CJC-1295 With DAC vs Without DAC
The short answer: the core peptide sequence is the same, but the pharmacokinetics are very different. The table below summarizes the main distinctions.
| Feature | CJC-1295 with DAC | CJC-1295 without DAC (Mod GRF 1-29) |
|---|---|---|
| Common names | CJC-1295 DAC, DAC:GRF | Mod GRF 1-29, CJC-1295 no DAC |
| Half-life | About 6 to 8 days | About 30 minutes |
| Albumin binding | Yes | No |
| Typical research frequency | Once weekly or less | One to three times daily |
| Growth hormone pattern | Sustained elevation | Short, pulsatile release |
| FDA status | Not approved for human use | Not approved for human use |
The common question what is cjc-1295 with dac vs without dac ultimately comes down to half-life and dosing frequency rather than any difference in the peptide itself.
Research Dosing Considerations
Because clearance is fast, a typical cjc 1295 without dac dosage per week is usually split into daily or twice-daily injections in research settings rather than one large weekly dose. Published human pharmacokinetic data for the no-DAC version remain limited.
Ranges circulating in research and community discussions — not clinical guidelines — generally fall near 100 mcg per injection, one to three times per day. Anyone considering peptides for personal use should speak with a licensed healthcare professional first, because these products are not approved medicines and dosing information online is often unverified.
Combining CJC-1295 Without DAC With Ipamorelin
CJC-1295 without DAC acts on GHRH receptors, while ipamorelin acts on the ghrelin receptor. Because the two pathways differ, researchers frequently study them together on the theory that the combination produces a larger GH pulse than either peptide alone.
A commonly referenced cjc-1295 without dac and ipamorelin dosage is 100 mcg of each peptide per injection, once or twice daily. That figure comes from community practice, however, not from large controlled trials.
Peptides sold online are research chemicals, not approved drugs. Purity, potency, and actual content can vary widely between suppliers.
Forum posts often repeat the same debates — including cjc 1295 with or without dac reddit discussions that compare the two versions — but personal anecdotes are not substitutes for clinical evidence.
Legal Status, Safety, and Sourcing
CJC-1295 in either form is not FDA-approved for human use and is sold as a research chemical. That means no standardized dosing, no pharmacy oversight, and no guarantee of purity.
Side effects reported in user accounts include injection site irritation, water retention, tingling or numbness in the hands, joint discomfort, and possible changes in blood sugar. These reports are anecdotal and have not been confirmed in controlled human trials.
For growth hormone-related conditions, FDA-approved options such as recombinant GH or approved GHRH analogs like tesamorelin are prescribed and monitored by physicians rather than purchased online.
Bottom Line
CJC-1295 without the drug affinity complex is the short-acting version of the peptide, and the DAC molecule is the single biggest difference between the two forms. The no-DAC version is generally studied with more frequent, lower-dose administration and is often paired with ipamorelin.
Nothing here is medical advice. Talk to a licensed healthcare professional before using any peptide, and treat online dosing charts with skepticism.
Frequently Asked Questions
Is CJC-1295 without DAC the same as Mod GRF 1-29?
Yes. Mod GRF 1-29 is another name for the tetra-substituted GRF 1-29 peptide that lacks the drug affinity complex. Both terms describe the same short-acting research peptide.
How long does CJC-1295 without DAC stay in your system?
Its reported half-life is roughly 30 minutes, which is far shorter than the 6 to 8 days seen with the DAC version. Most of the peptide is cleared within a few hours, which is why research protocols use more frequent administration.
Is CJC-1295 without DAC FDA approved?
No. CJC-1295 in any form is not FDA-approved for human use in the United States and is sold as a research chemical. Products marketed online are not pharmacy-grade medicines and are not subject to the same purity or labeling standards.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.